Find your missing element at CPHI Milan 2024
Discover a different kind of CDMO in Italy
Book a meeting with us at CPHI Milan to learn how our elements of partnership power pharmaceutical success.
We look forward to meeting you in Italy
CPHI is pharma’s biggest event of the year — an opportunity to uncover innovation at the source, learn about emerging trends, and connect with industry experts.
The event is widely referred to as being at the heart of pharma, and we believe that as an industry-leading, comprehensive CDMO and CRO, Thermo Fisher Scientific is at the heart of CPHI.
Schedule a meeting to discover what makes us a different kind of CDMO and CRO and how we can support your drug research, development, and manufacturing journey.
You can’t miss this: Thought leadership session
Be sure to attend Thermo Fisher Scientific’s thought leadership session at CPHI Milan: “Maximizing outsourcing and manufacturing success through strategic CDMO and CRO partnerships.”
Date: Wednesday, October 9, 2024
Time: 13:45 – 14:10 CEST
Location: CPHI Milan, Hall 5
Led by Jennifer Cannon, Ph.D., President of Commercial Operations at Thermo Fisher Scientific, this session will explore the dynamic evolution of CDMOs within the pharmaceutical industry.
Learn more below:
Attendees will gain insight into the evolution of CDMOs into essential collaborators for biotechnology and pharmaceutical companies. It will explore how these partnerships streamline the path to Investigational New Drug (IND) submission, optimize supply chains, mitigate risks, and accelerate the development and commercialization of new therapies.
Panel discussion: Navigating industry shifts in CDMO-pharma relations: Trends and Implications
Dr. Hrissi Samartzidou, VP of Commercial Strategy, Product, and Market Development at Thermo Fisher Scientific, will join in this panel discussion focusing on recent developments in the pharmaceutical industry, and how they’re driving significant transformation in the CDMO and CRO space.
Date: Tuesday, October 8, 2024
Time: 11:35 – 12:30 CEST
Location: CPHI Milan, Hall 5
Fireside chat: Navigating outsourcing partnerships for start-ups
Kelly Howard, Vice President, Commercial Operations, VVS Global and Advanced Therapies, will join this fireside chat on navigating outsourcing partnerships for start-ups, exploring effective strategies and best practices for collaborating with external partners to accelerate growth and drive innovation.
Date: Tuesday, October 8, 2024
Time: 13:15 – 13:30 CEST
Location: CPHI Milan, Hall 5
What’s going on at booth #7B18?
We’re excited to present two in-booth offerings: the Expert Café and the Drug Development Game.
Expert Café
Our experts will be available to provide guidance on accelerating your drug development journey and address any questions you may have about advancing your pharmaceutical product. You’re welcome to drop by for coffee and a conversation at any time. Alternatively, you can join one of our scheduled micro sessions with specialized SMEs. Session dates, times, and titles are below.
Tuesday, October 8:
- 14:00 CEST: Case study: An AcceleratorTM Drug Development case study: How Thermo Fisher’s strategic consultants aligned CRO and CDMO activities to meet an urgent clinical milestone
- Expert: Kevin Kane, CMC Strategy Director
Wednesday, October 9:
- 11:00 CEST: Protect and expand your IP
- Expert: Anil Kane, Senior Director, Global Technical Scientific Affairs
- 14:00 CEST: Financial solutions for cell and gene therapy development: Navigating high costs with flexible payment models
- Expert: Kelly Howard, Vice President, Commercial Operations, VVS Global and Advanced Therapies
Thursday, October 10:
- 11:00 CEST: Case study: Examples of how Thermo Fisher’s AcceleratorTM Drug Development can improve your asset success
- Expert: Kevin Kane, CMC Strategy Director
- 14:00 CEST: Critical success factors for consistency in sterile drug product manufacturing
- Expert: Alessandro Chreim, Global SME, Sterile Drug Products
Drug Development Game
Experience our educational game and gain insights into the drug development process. Spin the virtual wheel, navigate real-world scenarios, and learn how Thermo Fisher Scientific can support you from preclinical research to commercialization. As you progress, you’ll encounter key milestones and earn rewards, all while discovering our comprehensive capabilities.
Tour our state-of-the-art site in Monza
While you’re in Italy, visit our site in Monza, which specializes in the manufacturing and fill-finish of prefilled syringes, cartridges, liquid and lyophilized products, and mRNA.
We’re currently scheduling tours for Monday, October 7 from 12:00-16:00 CEST. We will provide transportation from the Monza train station to our state-of-the-art facility.
Leverage this opportunity to explore our end-to-end CDMO/CRO capabilities and connect with our local experts who help drug developers accelerate their time to market.
Find your missing element with Thermo Fisher Scientific
Insights and resources
Whitepaper
Transforming CDMO Partnerships Through Quality
Get an in-depth look into key indicators of CDMO quality, with tools and best practices to drive continuous improvement, strengthen collaboration, and ultimately cultivate trust.
View Infographic
Blog
Enter the CRDMO: Reshaping drug development through CRO/CDMO integration
CRDMOs, or integrated contract research, development, and manufacturing organizations, are a trend to watch. Discover five benefits of partnering with one.
Read Blog
Blog
The 5 drug development phases
To be deemed a “success,” a new drug must make it through five specific phases: 1) discovery and development, 2) preclinical research, 3) clinical research, 4) FDA review, and 5) safety monitoring.
Read Blog
Blog
CDMO 2.0: Three pharma industry trends for 2024 and beyond
Discover three major trends expected in the pharma industry, including turning to flexible manufacturing, embracing digital enablement, and the need for CDMOs deliver transformational value.
Read Blog
Blog
The quality lever: Shaping success in CDMO partnerships
Compromising on quality can lead to detrimental impacts on both speed and cost, ultimately affecting the successful development and marketing of new therapies.
Read Blog
Blog
Enter the CRDMO: Reshaping drug development through CRO/CDMO integration
CRDMOs, or integrated contract research, development, and manufacturing organizations, are a trend to watch. Discover five benefits of partnering with one.
Read Blog
Blog
What is a CDMO? Seven things to look for in a quality CDMO partner
Learn how CDMOs (contract development and manufacturing organizations) work with pharma companies, and the top considerations companies have when choosing a CDMO partner.
Read Blog
Blog
CROs vs CMOs, and CDMOs: What’s the difference between the three?
CROs, CMOs, and CDMOs all help biotechnology and pharmaceutical companies with drug development and manufacturing, but what’s the difference between the three?
Read Blog
Webinar
Optimizing the cell therapy patient journey through integrated CRO CDMO partnership
Watch this on-demand webinar for insights on how working with a single integrated CRO/CDMO partner can help ease industry challenges and provide an accelerated path from development to manufacturing, as well as the benefits that come from unified teams and infrastructure.
Infographic
CDMO Checklist to Launch Your Molecule Globally
Preparing to take your drug into the global market? You’ll need to make sure your CDMO has what it takes to successfully navigate the global regulatory space with speed, security, and supply safeguards. Use this quick list as a reference when evaluating your options.
View Infographic
Blog
Enabling a digital culture through integrated business processes
In contrast to a physical work environment, where stability and experience are key, a digital business environment focuses on innovation and connectivity. Learn more.
Whitepaper
The changing landscape of oncology drug development: Bringing novel lifesaving therapies to patients
Oncology is the fastest-growing, most active sector of drug development. Matching drug products to clinical and commercial needs requires scientific and technological innovation.
View Whitepaper
eBook
Protecting tomorrow: Supporting sustainability in the pharmaceutical and biotech industries
Learn how Thermo Fisher is meeting its environmental sustainability goals, and how we work in partnership with the pharma and biotech communities on shared environmental sustainability goals.
View eBook
Infographic
Preparing biologics for commercialization: Understanding Strategies to Reduce Risk and Optimize Outcomes in Drug Development
Within the drug development process, there are several steps that occur between the laboratory and final manufacture of the drug product. Different players step in during each point, so keeping a program with many moving parts on track requires planning and time-tested execution approaches.
View Infographic
Whitepaper
Advancing drug development using in silico modeling
This report provides a framework for that understanding by outlining some of the processes that stand to gain the most from computational modeling and identifying the in silico capabilities that can be used to accelerate and de-risk each phase of development.
Read WhitepaperDiscover a different kind of CDMO at CPHI
Continuing education for the pharma industry
Follow us on social for event updates